MedPath

Transcatheter Interventions for Tricuspid Insufficiency in Italy

Recruiting
Conditions
Tricuspid Valve Insufficiency
Registration Number
NCT04735003
Lead Sponsor
Marianna Adamo
Brief Summary

This is an observational, multi-center, retrospective and prospective study collecting data about patients undergoing transcatheter tricuspid valve interventions in a real world clinical environment. The aim is to report clinical characteristics, procedural results and short- and long-term outcomes of patients undergoing transcatheter tricuspid valve interventions in Italian centres.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
200
Inclusion Criteria
  1. Patients undergoing transcatheter treatment of tricuspid regurgitation (native valve -with or without previous surgical valve repair - or degenerated bioprosthesis)
  2. Patients who are willing and capable of providing informed consent, and participating in all follow-ups associated with this clinical investigation.
Exclusion Criteria
  1. Valve anatomy unsuitable for transcatheter tricuspid valve interventions.
  2. Subjects who are unable or not willing to complete follow-up visits and examination for the duration of the study.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
All-cause death1-year
Cardiovascular death or heart failure hospitalization1-year
Secondary Outcome Measures
NameTimeMethod
Changes in medical therapy (i.e. diuretic dose)30-day, 1-year and 5-year
Changes in right ventricular dimensions and function30-day, 1-year and 5-year
All-cause death5-year
Changes in liver and kidney function30-day, 1-year and 5-year
Changes in tricuspid regurgitation degree30-day, 1-year and 5-year
Changes in NYHA class30-day, 1-year and 5-year
Cardiovascular death or heart failure hospitalization5-year

Trial Locations

Locations (1)

Marianna Adamo

🇮🇹

Brescia, Lombardia, Italy

© Copyright 2025. All Rights Reserved by MedPath